Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

UroGen Pharma (URGN) Non Operating Income: 2015-2024

Historic Non Operating Income for UroGen Pharma (URGN) over the last 10 years, with Dec 2024 value amounting to -$669,000.

  • UroGen Pharma's Non Operating Income fell 79.65% to -$715,000 in Q4 2023 from the same period last year, while for Dec 2023 it was -$689,000, marking a year-over-year decrease of 161.98%. This contributed to the annual value of -$669,000 for FY2024, which is 2.90% up from last year.
  • UroGen Pharma's Non Operating Income amounted to -$669,000 in FY2024, which was up 2.90% from -$689,000 recorded in FY2023.
  • UroGen Pharma's Non Operating Income's 5-year high stood at $17,000 during FY2020, with a 5-year trough of -$689,000 in FY2023.
  • For the 3-year period, UroGen Pharma's Non Operating Income averaged around -$540,333, with its median value being -$669,000 (2024).
  • In the last 5 years, UroGen Pharma's Non Operating Income tumbled by 1,000.00% in 2021 and then grew by 2.90% in 2024.
  • UroGen Pharma's Non Operating Income (Yearly) stood at $17,000 in 2020, then tumbled by 1,000.00% to -$153,000 in 2021, then slumped by 71.90% to -$263,000 in 2022, then tumbled by 161.98% to -$689,000 in 2023, then rose by 2.90% to -$669,000 in 2024.